Hurco Companies heads into the final session of April having done something most of its industrial machinery peers have not: gone up on the week.
The stock gained nearly 1% over the past five days to close at $16.68, extending a 12.7% surge over the past month. That is a notably different story from the peer group. Ingersoll Rand fell more than 7% on the week. Graco dropped 7%. Gates Industrial lost 2.7%. Against that backdrop, Hurco's quiet outperformance is the standout feature of the week — the question is what is driving it.
Short interest has been drifting higher, and that drift warrants attention. Shorts have added roughly 7% to their position over the past week alone, pushing SI to 2.1% of the free float from around 1.9% a month ago. In isolation that is a modest level, barely worth flagging. But the directionality matters: the move came while the stock was rallying, meaning shorts and longs are currently pulling against each other. The borrow market remains loose. Cost to borrow has eased sharply — down 24% over the past month to 0.65% — and availability shows no sign of stress. Days to cover run 7.5 by official FINRA data and 5.6 by ORTEX estimate, so there is no near-term squeeze pressure. The ORTEX short score of 39.8 is ticking higher but remains well below territory that would signal extreme positioning — this is a build, not an accumulation.
Analysts are absent from this week's story. There is no current analyst consensus or price target data available for Hurco, which is consistent with the company's micro-cap status at roughly $106 million in market cap. Institutional ownership is concentrated and sticky: Brandes Investment Partners holds 7.8%, Oppenheimer & Close filed a new 13G in late April confirming a 7.1% stake with 29,670 shares added in Q1, and Dimensional Fund Advisors and Vanguard both added modestly in the quarter. That filing from Oppenheimer — the most recent corporate news of any substance — signals continued conviction from value-oriented holders. On the other side, Meros Investment Management and Peapod Lane Capital each trimmed positions in Q4 2025. The ownership structure tells a story of patient, deep-value investors willing to hold through a thin trading environment.
The insider register is worth noting, though the data is now more than 100 days old. In early January, the entire senior team — CEO Gregory Volovic, Executive Chairman Michael Doar, CFO Sonja McClelland, and General Counsel Jonathon Wright — all sold modest amounts at $16.30-$16.35. The sizes were small. All four transactions scored a significance rating of 1 out of 10. This reads as routine tax or compensation-related selling rather than a signal of conviction either way. The current price of $16.68 is essentially where those sales occurred, so no particular information has been revealed in the interim.
The most recent earnings history shows a mixed picture. The March 6 announcement produced a 6.6% one-day drop and a further 11.6% decline over the following five sessions — the sharpest post-earnings move in the dataset. An earlier January 9 call produced a 4.6% one-day gain. The stock is now trading back near levels that preceded both those events, suggesting the market has absorbed both reactions and reset. The screening data shows the RSI at 60.8 — firm but not stretched — and a next event flag that reads "to report Q4 2025 results," though no confirmed date has been announced.
The setup heading into May is one where a recovering stock faces a rebuilding short interest in an otherwise weak peer group, with no analyst coverage to provide a price anchor and a pending earnings release as the clearest upcoming catalyst to watch.
See the live data behind this article on ORTEX.
Open HURC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
